Elo Mutual Pension Insurance Co Has $2.34 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Elo Mutual Pension Insurance Co trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 20.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,125 shares of the company’s stock after selling 8,010 shares during the period. Elo Mutual Pension Insurance Co’s holdings in GE HealthCare Technologies were worth $2,337,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Dodge & Cox increased its position in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. Norges Bank acquired a new stake in GE HealthCare Technologies during the second quarter worth $468,120,000. Holocene Advisors LP increased its holdings in GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after buying an additional 2,581,522 shares during the period. Menora Mivtachim Holdings LTD. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $80,755,000. Finally, Balyasny Asset Management L.P. bought a new position in shares of GE HealthCare Technologies during the 2nd quarter worth about $58,388,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 1.1%

GEHC stock opened at $79.02 on Thursday. The business has a fifty day moving average price of $82.12 and a 200 day moving average price of $78.54. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The stock has a market capitalization of $36.01 billion, a price-to-earnings ratio of 17.33, a P/E/G ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The business’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on GEHC. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 price target on shares of GE HealthCare Technologies in a research note on Friday, January 9th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price target for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Finally, Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.